Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2063-2068

  Ansari, Kausar M ^a   Sung, You Me ^a   He, Guobin ^a   Fischer, Susan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN A; CYCLOOXYGENASE 2; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DNA SYNTHESIS; ENZYME INDUCTION; GENE DELETION; GENE OVEREXPRESSION; KERATINOCYTE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CELL CULTURE TECHNIQUES; CYCLOOXYGENASE 2; DINOPROSTONE; EPIDERMIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KERATINOCYTES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, PROSTAGLANDIN E; RNA; SKIN; SKIN PHYSIOLOGY; THYMIDINE;

EID: 35148889322     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm011     Document Type: Article

References (39)

1. Fischer,S.M. et al. (1999) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog., 25, 231-240.
2. Fischer,S.M. (2002) Is cyclooxygenase-2 important in skin carcinogenesis? J. Environ. Pathol. Toxicol. Oncol., 21, 183-191.
3. Orengo,I.F. et al. (2002) Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: A study in the hairless mouse model. Arch. Dermatol., 138, 751-755.
4. Conconi,M.T. et al. (1996) Relationship between the proliferation of keratinocytes cultured in vitro and prostaglandin E2. Ann. Anat. 178, 229-236.
5. Regan,J.W. (2003) EP2 and EP4 prostanoid receptor signaling. Life Sci., 74, 143-153.
6. Lee,J.L. et al. (2005) Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer. J. Invest. Dermatol., 125, 818-825.
7. Sung,Y.M. et al. (2005) Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development. Cancer Res., 65, 9304-9311.
8. Shaywitz,A.J. et al. (1999) CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem., 68, 821-861.
9. Sales,K.J. et al. (2001) Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: A possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J. Clin. Endocrinol. Metab., 86 2243-2249.
10. Bradbury,D.A. et al. (2003) Cyclooxygenase-2 induction by bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, E-prostanoid 2 (EP2), and EP4 receptors. J. Biol. Chem., 278, 49954-49964.
11. Desdouets,C. et al. (1995) Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol. Cell Biol., 15, 3301-3309.
12. Lee,R.J. et al. (1999) pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J. Biol. Chem., 274, 7341-7350.
13. Jean,D. et al. (2000) Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol. Cell Biochem., 212, 19-28.
14. Jean,D. et al. (2001) Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: Potential modality for cancer therapy. Crit. Rev. Immunol., 21, 275-286.
15. Abramovitch,R. et al. (2004) A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res., 64, 1338-1346.
16. Sonoshita,M. et al. (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat. Med., 7, 1048-1051.
17. Tilley,S.L. et al. (1999) Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J. Clin. Invest., 103, 1539-1545.
18. Sung,Y.M. et al. (2006) Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. Oncogene, 25, 5507-5516.
19. Chang,J. et al. (1986) Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis. Inflammation 10, 205-214.
20. Yuspa,S.H. et al. (1974) Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp. Cell Res. 86, 95-105.
21. Lu,X. et al. (1995) Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl Acad. Sci. USA, 92, 7961-7965.
22. Maldve,R.E. et al. (2000) Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J. Lipid Res., 41 873-881.
23. Lee,J.L. et al. (2003) Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol. Appl. Pharmacol., 192, 294-306.
24. Herschman,H.R. (1994) Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev., 13, 241-256.
25. Maldve,R.E. et al. (1996) Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol. Carcinog., 17, 207-216.
26. Goldyne,M.E. et al. (1994) 12-O-tetradecanoylphorbol-13-acetate and the induction of prostaglandin E2 generation by human keratinocytes: a reevaluation. Carcinogenesis, 15, 141-143.
27. Chang,S.H. et al. (2005) The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Cancer Res., 65, 4496-4499.
28. Chang,S.H. et al. (2005) Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor. Prostaglandins Other Lipid Mediat. 76, 48-58.
29. Konger,R.L. et al. (1998) Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim. Biophys. Acta, 1401, 221-234.
30. Sales,K.J. et al. (2004) Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. Mol. Endocrinol., 18, 1533-1545.
31. Sung,Y.M. et al. (2006) Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. Oncogene. 25, 5507-5516.
32. Sheng,H. et al. (2001) Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem., 276, 18075-18081.
33. Chang,S.H. et al. (2004) Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc. Natl Acad. Sci. USA, 101, 591-596.
34. Jabbour,H.N. et al. (2001) Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: A possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br. J. Cancer, 85, 1023-1031.
35. Watanabe,K. et al. (1999) Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res., 59, 5093-5096.
36. Mutoh,M. et al. (2002) Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res., 62, 28-32.
37. Kitamura,T. et al. (2003) Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Sci., 94, 618-621.
38. Kawamori,T. et al. (2005) Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development. Carcinogenesis, 26, 353-357.
39. Fujino,H. et al. (2005) Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol. Pharmacol., 68, 251-259.